HomepageVEE • ETR
add
Veeva Systems
Vorige slotkoers
€ 186,20
Jaar-range
€ 159,20 - € 241,40
Beurswaarde
38,63Â mld. USD
Primaire beurs
NYSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | jan 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 720,89Â mln. | 14,31% |
Bedrijfskosten | 351,47Â mln. | 9,35% |
Netto inkomsten | 195,62Â mln. | 32,72% |
Netto winstmarge | 27,14 | 16,13% |
Winst per aandeel | 1,74 | 26,09% |
EBITDA | 198,36Â mln. | 37,85% |
Effectief belastingtarief | 20,20% | — |
Balans
Totale activa
Totale passiva
(USD) | jan 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 5,15Â mld. | 27,87% |
Totale activa | 7,34Â mld. | 24,17% |
Totale passiva | 1,51Â mld. | 19,06% |
Totaal aandelenvermogen | 5,83 mld. | — |
Uitstaande aandelen | 162,70 mln. | — |
Koers-boekwaardeverhouding | 5,19 | — |
Rendement op activa | 6,83% | — |
Rendement op kapitaal | 8,21% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | jan 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 195,62Â mln. | 32,72% |
Operationele kasstroom | 69,54Â mln. | 20,38% |
Kasstroom uit beleggingen | -15,69Â mln. | 81,90% |
Kasstroom uit financiering | 20,81Â mln. | 298,50% |
Nettomutatie in liquide middelen | 74,27Â mln. | 284,65% |
Vrije kasstroom | 8,39Â mln. | -54,94% |
Over
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly-traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Opgericht
2007
Hoofdvestiging
Website
Werknemers
7.291